EVALUASI PENATALAKSANAAN MUAL MUNTAH KARENA KEMOTERAPI PADA PASIEN KANKER PARU DI INSTALASI RAWAT INAP RSUD Dr. MOEWARDI SURAKARTA TAHUN 2009 [PDF]
, 2010 Sebagian besar obat kemoterapi kanker paru merupakan obat dengan emetogenisitas tinggi. Penatalaksanaan mual dan muntah yang tidak tepat dapat menurunkan tingkat kepatuhan terhadap pengobatan dan menurunkan kualitas hidup pasien. Penelitian ini bertujuan
LESTARININGSIH , DIAH
core
Safety and efficacy of palonosetron compared in prevention of postoperative nausea and vomiting in patients undergoing elective major surgery under general anaesthesia [PDF]
, 2019 Background: Post-operative nausea and vomiting continues to be a common side effect of surgery and anaesthesia, affecting the economics of medical care, as well as the degree of patients’ satisfaction, comfort and quality of life.The objective of the ...
Baig, Mirza Shiraz, Godre, Neha
core +2 more sources
Brazilian Journal of AnesthesiologyBackground: We tested the hypothesis that, within the margin of 15% of risk difference, palonosetron is not inferior to ondansetron in reducing the incidence of postoperative nausea and vomiting (PONV) in laparoscopic cholecystectomy.
Francisco Jos.. Chiaradia Davolos +3 more
doaj +1 more source
Prophylaxis of post-operative nausea and vomiting in major obstetrics surgeries: a comparative study between palanosetron and neit guam point stimulation [PDF]
, 2017 Background: Post-operative nausea and vomiting (PONV) prophylaxis is an important component in providing safe anesthesia in antenatal women. Pharmaceutical interventions like metoclopramide and 5-HT3 antagonists are the current treatment of choice for ...
Agarwal, Apurva +3 more
core +2 more sources
Adding aprepitant to palonosetron does not decrease carboplatin-induced nausea and vomiting in patients with gynecologic cancer [PDF]
, 2021 Yuko Watanabe +4 more
openalex +1 more source
Journal of Anaesthesiology Clinical Pharmacology, 2010 Background: Postoperative nausea and vomiting (PONV) is commonly seen after laparoscopic surgery. In this randomized double blind prospective clinical study, we investigated and compared the efficacy of palonosetron and granisetron to prevent ...
Dhurjoti Prosad Bhattacharjee +5 more
doaj
Palonosetron for the prevention of chemotherapy induced nausea and vomiting: a comparative study in a tertiary care hospital from India [PDF]
, 2019 Background: Despite advances in symptom management, chemotherapy-induced nausea and vomiting (CINV) remains one of the most dreadful consequences of cancer therapy.Methods: The study was carried out at Medical Oncology Department, Vydehi Institute of ...
Nadig, Pratibha +3 more
core +2 more sources
Ondansetron versus palonosetron: a comparative study on efficacy and safety in prevention of postoperative nausea and vomiting [PDF]
, 2016 Background: Postoperative nausea and vomiting (PONV) is a major complication in patients who undergo surgery under general anaesthesia. Various drug regimens and antiemetic interventions have been tried from time-to-time for prevention of PONV but with a
B., Vasundara Devi +5 more
core +3 more sources
Recommendations for prevention and treatment of nausea and vomiting in systemic oncology treatment [PDF]
, 2018 Slabost in bruhanje ostajata kljub velikemu napredku najpogostejša neželena učinka sistemskega zdravljenja, ki bistveno zmanjšata bolnikovo kvaliteto življenja in zmanjšata njegovo komplianco za nadaljevanje sistemskega zdravljenja.
Hribernik, Nežka, Reberšek, Martina
core +1 more source
Palonosetron on Days 1 and 5 Versus Granisetron Daily (Days 1-5) in Germ Cell Tumour Therapy [PDF]
, 2019 Yusuke Shimura +8 more
openalex +1 more source